Antonio Nicolucci
Antonio Nicolucci publishes mostly in Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management and Diabetes Management and Research.
- World rank
- #115,093 of 7,710,434 ranked researchers
- Rank in Italy
- #2,293 of 242,206
- Works
- 474
- Citations
- 26k
- Citations per work
- 55.7
What does Antonio Nicolucci research?
Antonio Nicolucci's work is mostly in Medicine (61%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences29061.2%
- Medicine29061.2%
- Everything else16635.0%
- Life Sciences183.8%
- 1Endocrinology, Diabetes and Metabolism42% of their works
- 2Cardiology and Cardiovascular Medicine6% of their works
- 3Surgery5% of their works
- 4Epidemiology4% of their works
- 5Nephrology4% of their works
- 6Genetics4% of their works
Research topics
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes Management and Education
- Chronic Kidney Disease and Diabetes
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Chronic Disease Management Strategies
- Diabetes and associated disorders
Which keywords describe Antonio Nicolucci's research?
The keywords of their largest research topics: Glycemic Control, Diabetes, Cardiovascular Disease, Insulin Therapy, Type 1 Diabetes, Insulin Resistance, Metabolic Syndrome and Cardiovascular Outcomes.
- Autoimmunity
- Chronic Conditions
- Critical Care
- Chronic Kidney Disease
- Self-Management
- Primary Care
- Continuous Glucose Monitoring
- Cardiovascular Outcomes
- Insulin Resistance
- Insulin Therapy
- Diabetes
- Glycemic Control
- Cardiovascular Disease
- Type 1 Diabetes
- Metabolic Syndrome
- Type 2 Diabetes
- Hypoglycemia
- Depression
- Epidemiology
- Glomerular Filtration Rate
- Hyperglycemia
- Multimorbidity
- Genetics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Glycemic Control3614 topics
- Diabetes3343 topics
- Cardiovascular Disease2843 topics
- Insulin Therapy2773 topics
- Type 1 Diabetes1442 topics
- Insulin Resistance1331 topic
- Metabolic Syndrome1331 topic
- Cardiovascular Outcomes1271 topic
- Type 2 Diabetes1271 topic
- Continuous Glucose Monitoring1171 topic
- Hypoglycemia1171 topic
- Primary Care1122 topics
- Depression841 topic
- Self-Management841 topic
- Epidemiology552 topics
- Chronic Kidney Disease341 topic
- Glomerular Filtration Rate341 topic
- Critical Care331 topic
- Hyperglycemia331 topic
- Chronic Conditions281 topic
- Multimorbidity281 topic
- Autoimmunity271 topic
- Genetics271 topic
Where does Antonio Nicolucci work?
Antonio Nicolucci's main affiliation in the publication record is Center for Outcomes Research and Clinical Epidemiology, Italy.
How many publications and citations does Antonio Nicolucci have?
OpenAlex counts 474 works and 26,415 citations for Antonio Nicolucci, an h-index of 77, ranking #115,093 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Antonio Nicolucci
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Antonio Nicolucci. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.